glp 1 for addiction treatment GLP-1s and Treatment: Setting a Thoughtful Standard Examining the consequences of discontinuing

Let's explore a comparison of the various GLP-1 analogues discussed in this blog: semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide

Overall, however, the modest reduction in fasting LDL-C (25 mg/dL) observed with GLP-1R agonists in T2DM trials may not be sufficient to fully explain their cardioprotective actions

The discontinuation profile proves more favorable than retinoids showing rapid rebound and high dependency, while similar to vitamin C and niacinamide demonstrating moderate benefit retention and low dependency patterns

The market is expected to grow its GLP-1 drug share from 45% to 1520% within 18 months

Hansen, C